9-Hexadecenoylcarnitine

Metabolite details

Identifier

ZVOMLLYYTWFWOA-XPTLAUCJSA-N

InChI Key

ZVOMLLYYTWFWOA-XPTLAUCJSA-N

IUPAC name

Preferred name

9-Hexadecenoylcarnitine

INN name

—

Synonym

(4S)-4-[(9Z)-hexadec-9-enoyloxy]-4-(trimethylazaniumyl)butanoate

ChEBI

CHEBI:88544

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Metabolic characterization of the natural progression of chronic hepatitis B (Biogenic amine and Acyl-carnitine assays).

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant